<?xml version="1.0" encoding="UTF-8"?>
<list list-type="simple">
 <list-item>
  <label>1.</label>
  <p>Histologically proven ESCC.</p>
 </list-item>
 <list-item>
  <label>2.</label>
  <p>Clinically diagnosed Stage II or Stage III ESCC staged according to the 11
   <sup>th</sup> edition of the Japanese Classification of Esophageal Cancer.
   <sup>[
    <xref rid="R11" ref-type="bibr">11</xref>,
    <xref rid="R12" ref-type="bibr">12</xref>]
   </sup>
  </p>
 </list-item>
 <list-item>
  <label>3.</label>
  <p>Patients considered eligible for radical esophagectomy under general anesthesia.</p>
 </list-item>
 <list-item>
  <label>4.</label>
  <p>Aged between 20 and 74 years at the time of enrollment.</p>
 </list-item>
 <list-item>
  <label>5.</label>
  <p>Patients with ECOG performance status 0, 1, or 2.</p>
 </list-item>
 <list-item>
  <label>6.</label>
  <p>Confirmed adequate organ functions within 14 days before enrollment. The following clinical test standards were used:</p>
  <list list-type="simple">
   <list-item>
    <label>a.</label>
    <p>Creatine ≤1.2 mg/dL</p>
   </list-item>
   <list-item>
    <label>b.</label>
    <p>Blood urea nitrogen ≤25 mg/dL</p>
   </list-item>
   <list-item>
    <label>c.</label>
    <p>Creatinine clearance ≥60 mL/min</p>
   </list-item>
   <list-item>
    <label>d.</label>
    <p>Total bilirubin ≤1.2 mg/dL</p>
   </list-item>
   <list-item>
    <label>e.</label>
    <p>Glutamic oxaloacetic transaminase, glutamic pyruvic transaminase ≤twice the upper limit of the institutional reference value</p>
   </list-item>
   <list-item>
    <label>f.</label>
    <p>White blood cell count ≥4000 cells/mm
     <sup>3</sup>
    </p>
   </list-item>
   <list-item>
    <label>g.</label>
    <p>Hemoglobin ≥8.0 g/dL</p>
   </list-item>
   <list-item>
    <label>h.</label>
    <p>Platelet count ≥100,000 cells/mm
     <sup>3</sup>
    </p>
   </list-item>
   <list-item>
    <label>i.</label>
    <p>PaO
     <sub>2</sub> ≥70 torr
    </p>
   </list-item>
  </list>
 </list-item>
 <list-item>
  <label>7.</label>
  <p>Patients who can take medicine.</p>
 </list-item>
 <list-item>
  <label>8.</label>
  <p>Oral and written informed consent obtained before registration.</p>
 </list-item>
</list>
